Internal controls (11 - 20 of 20 items) in Past 6 Months
Controlled Substances: DEA Should Take Additional Actions to Reduce Risks in Monitoring the Continued Eligibility of Its Registrants
GAO-16-310: Published: May 26, 2016. Publicly Released: Jun 21, 2016.
Medical Product Oversight: FDA Needs More Strategic Planning to Guide Its Scientific Initiatives
GAO-16-432: Published: May 16, 2016. Publicly Released: Jun 15, 2016.
Medicare Fee-For-Service: Opportunities Remain to Improve Appeals Process
GAO-16-366: Published: May 10, 2016. Publicly Released: Jun 9, 2016.
VA Health Care: Improvements Needed for Management and Oversight of Sole-Source Affiliate Contract Development
GAO-16-721T: Published: Jun 7, 2016. Publicly Released: Jun 7, 2016.
Medicare Program: Continued Action Required to Address Weaknesses in Provider and Supplier Enrollment Controls
GAO-16-703T: Published: May 24, 2016. Publicly Released: May 24, 2016.
Medicare: Claim Review Programs Could Be Improved with Additional Prepayment Reviews and Better Data
GAO-16-394: Published: Apr 13, 2016. Publicly Released: May 13, 2016.
Medicare Advantage: Action Needed to Ensure Appropriate Payments for Veterans and Nonveterans
GAO-16-137: Published: Apr 11, 2016. Publicly Released: May 11, 2016.
Medicare Advantage: Fundamental Improvements Needed in CMS's Effort to Recover Substantial Amounts of Improper Payments
GAO-16-76: Published: Apr 8, 2016. Publicly Released: May 9, 2016.
Medicaid Program Integrity: Improved Guidance Needed to Better Support Efforts to Screen Managed Care Providers
GAO-16-402: Published: Apr 22, 2016. Publicly Released: May 6, 2016.
Indian Health Service: Actions Needed to Improve Oversight of Patient Wait Times
GAO-16-333: Published: Mar 29, 2016. Publicly Released: Apr 28, 2016.